Cagent Vascular Emphasizes Serration Remodeling Therapy in Complex PAD Care

According to a recent LinkedIn post from Cagent Vascular Inc, the company is emphasizing its Serration Remodeling Therapy (SRT) as a tool for managing increasingly complex peripheral arterial disease (PAD) cases. The post highlights collaborations with physicians, including recognition of Dr. Lichtenberg, and underscores clinical priorities such as luminal gain, reduced recoil, and fewer dissections across varied lesion types.

The content suggests Cagent Vascular is positioning SRT as a differentiated endovascular technology within the PAD treatment algorithm. For investors, this focus on physician engagement and procedural durability may indicate an effort to drive adoption, support potential revenue growth in the PAD device segment, and strengthen the firm’s competitive standing in vascular intervention markets.